Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency-Reference-Cited by-同舟云学术

Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

Published:2006-05-17 Issue:4 Volume:26 Page:388-395
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Church Joseph A.,Leibl Heinz,Stein Mark R.,Melamed Isaac R.,Rubinstein Arye,Schneider Lynda C.,Wasserman Richard L.,Pavlova Borislava G.,Birthistle Karl,Mancini Marianne,Fritsch Sandor,Patrone Lisa,Moore-Perry Kerry,Ehrlich Hartmut J.,

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-006-9025-3.pdf

Reference24 articles.

1. Rosen FS, Cooper MD, Wedgwood RJ: The primary immunodeficiencies. N Engl J Med 333:431–440, 1995

2. IUIS Scientific Committee: Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 118:1–28, 1999

3. Cooper MD, Lanier LL, Conley ME, Puck JM: Immunodeficiency disorders. Hematology (Am Soc Hematol Educ Program):314–330, 2003

4. Schwartz SA: Intravenous immunoglobulin treatment of immunodeficiency disorders. Pediatr Clin North Am 47:1355–1369, 2000

5. Durandy A, Wahn V, Petteway S, Gelfand EW: Immunoglobulin replacement therapy in primary antibody deficiency diseases-maximizing success. Int Arch Allergy Immunol 136:217–229, 2005

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initiating immunoglobulin replacement therapy helps reduce severe infections and shifts healthcare resource utilization to outpatient services among US patients with inborn errors of immunity;Journal of Medical Economics;2024-07

2. A systematic review of population pharmacokinetic analyses of polyclonal immunoglobulin G therapy;International Immunopharmacology;2021-08

3. Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies;Frontiers in Immunology;2021-07-08

4. Safety and tolerability of IgPro10 in Japanese primary immunodeficiency patients: a registrational study;International Journal of Hematology;2021-03-18

5. A New Intravenous Immune Globulin: Novel or Not?;Annals of Pharmacotherapy;2020-06-21